Jazz Pharmaceuticals
JAZZ
JAZZ
339 hedge funds and large institutions have $7.07B invested in Jazz Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 127 increasing their positions, 121 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
11% less capital invested
Capital invested by funds: $7.92B → $7.07B (-$844M)
13% less call options, than puts
Call options by funds: $101M | Put options by funds: $117M
Holders
339
Holding in Top 10
10
Calls
$101M
Puts
$117M
Top Buyers
| 1 | +$109M | |
| 2 | +$33M | |
| 3 | +$31M | |
| 4 |
Prudential Financial
Newark,
New Jersey
|
+$26.2M |
| 5 |
Renaissance Technologies
New York
|
+$25.6M |
Top Sellers
| 1 | -$94.1M | |
| 2 | -$87.2M | |
| 3 | -$77.5M | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
-$58.5M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$52.3M |